– CNBC
Cowen & Co. Downgrades Teladoc Health to Market Perform, Lowers Price Target to $34
Cowen & Co. analyst Charles Rhyee downgrades Teladoc Health (NYSE:TDOC) from Outperform to Market Perform and lowers the price target from $58 to $34.